European Journal of Chemistry

Synthesis, reactions and biological evaluation of benzyltriazolophthalazine derivatives

Main Article Content

Ashraf Hassan Fekry Abd El-Wahab
Hany Mostafa Mohamed
Ahmed Mohamed El-Agrody
Mohamed Ahmed El-Nassag
Ahmed Hammam Bedair


A series of triazolophthalazine derivatives (4-22) were synthesized and characterized. The structures of the newly synthesized compounds were confirmed by spectral data. The newly synthesized compounds were also screened for their antimicrobial activity.


icon graph This Abstract was viewed 1908 times | icon graph Article PDF downloaded 1337 times

How to Cite
El-Wahab, A. H. F. A.; Mohamed, H. M.; El-Agrody, A. M.; El-Nassag, M. A.; Bedair, A. H. Synthesis, Reactions and Biological Evaluation of Benzyltriazolophthalazine Derivatives. Eur. J. Chem. 2013, 4, 10-19.

Article Details

Crossref - Scopus - Google - European PMC

[1]. Juan, L.; Yan-Fang, Z.; Yuan, Xiao-Ye, Y.; Jing-Xiong, X.; Ping, G. Molecules 2006, 11, 574-582.

[2]. Jin, S. K.; Hee-Kyung, R.; Hyen, J. P.; Sang, K. L.; Chong-Ock, L.; Hea-Young, P. C. Bioorg. Med. Chem. 2008, 16, 4545-4550.

[3]. Raposo, M. M.; Sampaio, A. M. B. A.; Kirsch, G. J. Hetero. Chem. 2005, 42, 1245-1451.

[4]. Haack, T.; Fattori, R.; Naboletano, M.; Pellacini, F.; Fronza, G.; Raffaini, G.; Janazzoli, F. Bioorg. Med. Chem. 2005, 13, 4425-4433.

[5]. Napoletano, M.; Norcini, G.; Pellacini, F.; Marchini, F.; Morazzoni, G.; Fattori, R.; Ferienga, P.; Pradella, L. Bioorg. Med. Chem. Lett. 2002, 12, 5-8.

[6]. Napoletano, M.; Norcini, G.; Pellacini, F.; Marchini, F.; Morazzoni, G.; Fattori, R.; Ferienga, P.; Pradella, L. Bioorg. Med. Chem. Lett. 2001, 11, 33-37.

[7]. Line, B.; Andre, T.; Patricia, M. Tertrahedron Lett. 1996, 37, 4145-4148.

[8]. Reddy, R. S.; Saravanan, K.; Kumar, P. Tertrahedron 1998, 54, 6553-6564.

[9]. Gomha, S. M.; Riyadh, S. M. Molecules 2011, 16, 8244-8256.

[10]. El-Sakka, S. S.; Soliman, A. H.; Imam, A. M. Afinidad 2009, 66, 167-172.

[11]. Tsoungas, P. G.; Searcey, M. Tetrahedron Lett. 2001, 42, 6589-6592.

[12]. Sivakumar, R.; Gnanasam, S. K.; Ramachandran, S.; Leonard, J. T. Eur. J. Med. Chem. 2002, 37, 793-801.

[13]. Coelho, A.; Sotelo, E.; Fraiz, N. M.; Yanez, M.; Laguna, R.; Canob, E.; Ravina, E. Bioorg. Med. Chem. Lett. 2004, 14, 321-324.

[14]. Demirayak, S.; Karaburun, A. C.; Beis, R. Eur. J. Med. Chem. 2004, 39, 1089-1095.

[15]. Dogruer, D. S.; Sahin, M. F.; Unlu, S.; Ito, S. Arch. Pharm. 2000, 333, 79-86.<79::AID-ARDP79>3.0.CO;2-S

[16]. Norbert, H.; Tamara, K.; Johann, K.; Angelika, P. Molecules 2007, 12, 1900-1909.

[17]. Imamura, Y.; Noda, A.; Imamura, T.; Ono, Y.; Okawara, T.; Noda, H. Life Sci. 2003, 74, 29-36.

[18]. Dogruer, D. S.; Sahin, M. F.; Kupeli, E.; Yesilada, E. Turk. J. Chem. 2003, 27, 727-738.

[19]. Dogruer, D. S.; Sahin, M. F.; Kupeli, E.; Yesilada, E. Arch. Pharm. 2004, 337, 303-310.

[20]. Bold, G.; Altmann, K. -H.; Frei, J.; Lang, M.; Manley, P. W.; Traxler, P.; Wietfeld, B.; Brueggen, J.; Buchdunger, E.; Cozens, R.; Ferrari, S.; Furet, P.; Hofmann, F.; MartinyBaron, G.; Mestan, J.; Roesel, J.; Sills, M.; Stover, D.; Acemoglu, F.; Boss, E.; Emmenegger, R.; Laesser, L.; Masso, E.; Roth, R.; Schlachter, C.; Vetterli, W.; Wyss, D.; Wood, J. M. J. Med. Chem. 2000, 43, 2310-2323.

[21]. Stuart, L. F.; Daniel, F. M.; Peter, K. Nature Reviews Drug Discovery, 2005, 4, 187-188.

[22]. Hennequin, L. F.; Stokes, E. S.; Thomas, A. P.; Johnstone, C; Ple, P. A.; Ogilvie, D. J.; Dukes, M.; Wedge, S. R.; Kendrew, J.; Curwen, J. O. J. Med. Chem. 2002, 45, 1300-1312.

[23]. Piatnitski, E. L.; Duncton, M. A.; Kiselyov, A. S.; Katoch, R. R.; Sherman, D.; Milligan, D. L.; Balagtas, C.; Wong, W. C.; Kawakami, J.; Doody, J. F. Bioorg. Med. Chem. Lett. 2005, 15, 4696-4698.

[24]. Matthew, A. J. D.; Evgueni, L. P.; Reeti, K. R; Leon, M. S.; Alexander, S. K.; Daniel, L. M.; Chris, B; Wai, C. W.; Joel, K.; Jacqueline, F. D. Bioorg. Med. Chem. Lett. 2006, 16, 1579-1581.

[25]. Bromber, A. Ber. 1896, 29, 1434-1435.

[26]. Ashraf, H. F. A; Hany, M. M.; Ahmed, M. E; Mohammed, A. E.; Ahmed, H. B. Pharmaceuticals 2011, 4, 1158-1170

[27]. European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution. Clin. Microbiol. Infect. 2000, 6, 509-515.

[28]. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 5th ed.; NCCLS: Wayne, PA, USA, 2000; Approved Standard M7-A5.

Supporting Agencies

Most read articles by the same author(s)

Most read articles by the same author(s)


Dimensions - Altmetric - scite_ - PlumX

Downloads and views


Download data is not yet available.


Metrics Loading ...
License Terms

License Terms


Copyright © 2024 by Authors. This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License ( By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution, or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License ( are administered by Atlanta Publishing House LLC (European Journal of Chemistry).